The KCNJ11 gene was markedly upregulated in kidney chromophobe and prostate adenocarcinoma, kidney renal papillary cell carcinoma, breast cancer, uterine carcinosarcoma, and uterine corpus endometrial carcinoma (Figure 7). This evidence concerns the gene KCNJ11 and prostate adenocarcinoma.